China | Hong Kong

Ashurst Leads Luye Pharma's Hong Kong IPO

, The Asian Lawyer

   | 0 Comments

The Chinese drugmaker is going public for the second time, having delisted from the Singapore Exchange two years ago.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202661847846

Thank you!

This article's comments will be reviewed.